ArticleMolecular and clinical oncology2020

A meta-analysis of serological thymidine kinase 1 as a marker for colorectal benign and malignant tumor risk assessment.

Li Dang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.